● Recruiting

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Condition: Cardiovascular Disease and Lipoprotein(a) · Sponsor: Novartis Pharmaceuticals

PhasePhase 3

Planned participants5700

Who can joinAll sexes, 18 Years to 100 Years

Healthy volunteersNo

About this study

This open-label extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed the double-blind parent study (CTQJ230A12301).

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (635)

SEC Clinical Research LLC	Andalusia, Alabama, United States	Recruiting
Heart Center Research Llc	Huntsville, Alabama, United States	Recruiting
Mobile Heart Specialists	Mobile, Alabama, United States	Recruiting
Mercy Gilbert Medical Center	Gilbert, Arizona, United States	Recruiting
Clinical Research Inst of Arizona	Sun City West, Arizona, United States	Recruiting
Eclipse Clinical Research	Tucson, Arizona, United States	Recruiting
Cardiology and Medicine Clinic PA	Little Rock, Arkansas, United States	Recruiting
Cardiovascular Res Found	Beverly Hills, California, United States	Recruiting
National Heart Institute	Beverly Hills, California, United States	Recruiting
Valley Clinical Trials Inc	Covina, California, United States	Recruiting
Diabetes Lipid Management Center	Huntington Beach, California, United States	Recruiting
University of Calif Irvine Med Cntr	Irvine, California, United States	Recruiting

+ 623 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07517263